COVID-19, Public Health Ethics, and Policy for Pandemics
Channel: HMS Center for Bioethics
Date: 08/04/2021

September 11, 2020

Since the SARS-CoV-2 pandemic began, scientific recommendations about the best way to reduce its impact have met wide-ranging resistance in the U.S. With two experts in infectious disease epidemiology and ethics, we will review how scientific evidence is collected in a rapidly changing public health environment, and how to translate that evidence into actionable recommendations. We will also discuss the sources of controversy that have arisen as the pandemic has evolved, including balancing individual and public health interests and how to manage different types of uncertainty. 

Presented by 
Marc Lipsitch, DPhil
Matthew Wynia, MD, MPH

Moderated by 
Leah Rand, PhD, MA

Organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.